AGIRX
Price
$17.37
Change
-$0.10 (-0.57%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

AGIRX vs RPTIX

Header iconAGIRX vs RPTIX Comparison
Open Charts AGIRX vs RPTIXBanner chart's image
Alger Mid Cap Growth Institutional R
Price$17.37
Change-$0.10 (-0.57%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AGIRX vs RPTIX Comparison Chart
Loading...
VS
AGIRX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIRX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. AGIRX (67.3M). RPTIX pays higher dividends than AGIRX: RPTIX (0.18) vs AGIRX (0.00). AGIRX was incepted earlier than RPTIX: AGIRX (22 years) vs RPTIX (9 years). AGIRX is a more actively managed with annual turnover of: 79.60 vs. RPTIX (21.70). AGIRX has a lower initial minimum investment than RPTIX: AGIRX (0) vs RPTIX (500000). AGIRX annual gain was more profitable for investors over the last year : 24.79 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. AGIRX (-38.94).
AGIRXRPTIXAGIRX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years9 years-
Gain YTD12.8559.127141%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets67.3M31.4B0%
Annual Yield % from dividends0.000.18-
Returns for 1 year24.7914.81167%
Returns for 3 years-59.77-13.57440%
Returns for 5 years-38.9415.09-258%
Returns for 10 years-15.60N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp